Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?
4.5 (620) · € 5.00 · En stock
.jpg)
Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis
Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro
Researchers evaluate artemisinin for COVID-19 management
Molecules, Free Full-Text
IJMS, Free Full-Text
Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats [
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect
Plants, Free Full-Text
SciELO - Brasil - Approach of utilizing Artemisia herbs to treat covid-19 Approach of utilizing Artemisia herbs to treat covid-19
Frontiers Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus
